Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Research News
Donate
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
  • Ken Griffin Alpha-Synuclein Imaging Competition B

    Promising Results and Next Steps in the “Ken Griffin Alpha-synuclein Imaging Competition”

    Today, The Michael J. Fox Foundation (MJFF) announced the culmination of the “Ken Griffin Alpha-synuclein Imaging Competition,” a $10-million program launched in 2019 in pursuit of a game-changing…
    Learn more
  • Researching testing items in a lab

    Research Roundup: Parkinson’s Studies Recruiting for Everything from Smell Loss to Genetic Variants

    The Michael J. Fox Foundation shares recruiting studies aimed at treating Parkinson’s symptoms and slowing disease progression.
    Learn more
  • Two researchers in lab looking at samples

    PPMI Dispatch: Predicting Cognitive Changes and Lipid Levels with a LRRK2 Mutation

    Read the latest scientific findings out of MJFF’s landmark study, the Parkinson’s Progression Markers Initiative, including new insights related to cognitive changes, new LRRK2 findings and…
    Learn more
  • Watch and Learn: Gaining Insight on Parkinson's Using Wearable Technology

    What We Fund: $51M with an App to Improve Speech and Therapies to Ease Cognition and Stop Disease

    The Michael J. Fox Foundation announces 88 grants that total more than $51 million toward studies developing new tools for treatment of Parkinson’s symptoms and disease.

    Learn more
  • Award recipient, Bruce Morimoto

    MJFF Confers J. William Langston Award on Scientific Advisor Bruce Morimoto, PhD

    This award honoring an MJFF advisor recognizes Bruce Morimoto, PhD, and his contributions to our Foundation strategy and patient impact.
    Learn more
  • Gene Therapy to Enhance Levodopa Response Progressing in Clinical Trials

    New Parkinson’s Drug Formulation Shows Positive Phase III Trial Results

    In a Phase III clinical trial, Neuroderm’s liquid, under-the-skin levodopa/carbidopa controls symptoms better than levodopa pills in people with progressing Parkinson’s.
    Learn more
  • Doctor and two people in clinic room

    Research Roundup: Recruiting Studies for Better Parkinson’s Treatment

    The Michael J. Fox Foundation shares studies recruiting volunteers aimed to treat Parkinson’s.
    Learn more
Close-up portrait

Join the Study that Could Change Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
Todd Sherer, PhD
Todd Sherer, PhD Chief Mission Officer
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.
Here. Until Parkinson's isn't.
Join us as we work to find a cure for the 6 million people worldwide living with Parkinson's.
 
 
 
 
Month
Day
Year